Literature DB >> 25090943

Connective tissue diseases: mTORC is a potential therapeutic target in APS.

João H Duarte.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25090943     DOI： 10.1038/nrrheum.2014.134

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Inhibition of the mTORC pathway in the antiphospholipid syndrome.

Authors:  Guillaume Canaud; Frank Bienaimé; Fanny Tabarin; Guillaume Bataillon; Danielle Seilhean; Laure-Hélène Noël; Marie-Agnès Dragon-Durey; Renaud Snanoudj; Gérard Friedlander; Lise Halbwachs-Mecarelli; Christophe Legendre; Fabiola Terzi
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.